PDC and prostate carcinoma: In contrast, PDC cytotoxicity against prostate cancer cells from patient LA08 reached 57% at 10 μM of PDC, representing a 3–14-fold greater selectivity of the PDC for prostate cancer cells than for normal prostate cells.